Engineered baker’s yeast as whole-cell biocatalyst for one-pot stereo-selective conversion of amines to alcohols
© Weber et al.; licensee BioMed Central Ltd. 2014
Received: 4 June 2014
Accepted: 2 August 2014
Published: 12 August 2014
One-pot multi-step biocatalysis is advantageous over step-by-step synthesis as it reduces the number of process operation units, leading to significant process intensification. Whole-cell biocatalysis with metabolically active cells is especially valuable since all enzymes can be co-expressed in the cell whose metabolism can be exploited for supply of co-substrates and co-factors.
In this study, a heterologous enzymatic system consisting of ω-transaminase and ketone reductase was introduced in Saccharomyces cerevisiae, and evaluated for one-pot stereo-selective conversion of amines to alcohols. The system was applied for simultaneous kinetic resolution of racemic 1-phenylethylamine to (R)-1-phenylethylamine and reduction of the ketone intermediate to (R)-1-phenylethanol. Glucose was used as sole co-substrate for both the supply of amine acceptor and the regeneration of NADPH in the reduction step.
The whole-cell biocatalyst was shown to sustain transaminase-reductase-catalyzed enantioselective conversion of amines to alcohols with glucose as co-substrate. The transamination catalyzed by recombinant vanillin aminotransferase from Capsicum chinense proved to be the rate-limiting step as a three-fold increase in transaminase gene copy number led to a two-fold increased conversion. The (R)-selective NADPH-dependent alcohol dehydrogenase from Lactobacillus kefir proved to be efficient in catalyzing the reduction of the acetophenone generated in the transamination reaction.
KeywordsTransamination Reduction VAMT Saccharomyces cerevisiae Capsicum chinense Lactobacillus kefir NADPH regeneration Pyruvate PLP Kinetic resolution Asymmetric synthesis
Chiral amine and/or chiral alcohol moieties are present in many bioactive molecules, e.g. Saxagliptin, which is used for the treatment of type 2 diabetes; Vanlev, an antihypertensive drug; Rivastigmine for the treatment of Alzheimer’s disease and the HIV protease inhibitors Atazanavir and Indinavirsulphate [1–3]. Consequently, efficient methods for preparation of bioactive compounds with chiral amine and/or alcohol functionalities, including their inter-conversion and inversion of stereochemistry are needed. Chemical methods where chiral amines are first transformed into intermediates and subsequently into chiral alcohols with inversion of the stereochemistry have been previously described [4–6]. Additionally, a mixture of diethylene glycol and KOH at 210°C converts several amines into alcohols in a one-pot reaction, albeit with limited enantiomeric purity , which highlights main limitations of chemical synthesis. As an alternative, biocatalytic methods based on isolated alcohol oxidase and ω-transaminase enzymes for one-pot conversion of alcohols to amines  and conversion of amines to alcohols with ω-transaminase-oxidoreductase enzymes  have been described. However, these methods rely on the addition of multiple enzymes, expensive co-substrates and in vitro co-factor regeneration systems. As an alternative, whole-cell biocatalysis with recombinant Pichia pastoris over-expressing a transaminase combined with endogenous reductase activity has previously been described for the conversion of amines to alcohols . Additionally, it has been demonstrated, that recombinant Saccharomyces cerevisiae expressing ω-transaminase can be used for kinetic resolution of racemic amines with glucose as sole co-substrate for the supply of amine acceptor and pyridoxal-5’-phosphate by cell metabolism . Engineered yeast has also been developed for efficient stereo-selective carbonyl reductions of prochiral ketones for the synthesis of chiral alcohols (see review  or ). In that case, cell metabolism was exploited for in vivo regeneration of the NADPH co-factor [14,15].
Transamination and product inhibition
Assembly of functional transaminase - oxidoreductase cascade in yeast
Strains and plasmids used in this study
Plasmids and strains
Codon-optimised VAMT encoding gene; AMP resistance gene
pUC57 LK RADH
Codon-optimised LK RADH encoding gene; AMP resistance gene
GenScript, NJ, USA
Plasmid with HXT7 truncated promoter and PGK terminator; AMP resistance gene; LEU2 gene
TDH3 promoter, ADH1 terminator, XDH under PGK1 promoter, with PGK1 terminator; URA3 gene; AMP resistance gene
VAMT gene under HXT7 truncated promoter, with PGK1 terminator, LEU2 gene; AMP resistance gene
VAMT under TDH3 promoter, with ADH1 terminator; LK RADH under PGK1 promoter, with PGK1 terminator; URA3 gene; AMP resistance gene
VAMT under TDH3 promoter, with ADH1 terminator; URA3 gene; AMP resistance gene
S. cerevisiae TMB4150
CEN.PK2-1C MATa ura3-52 MAL2-8 C SUC2, TRP1, LEU2, HIS3
Jan Knudsen, unpublished
S. cerevisiae TMB4350
CEN.PK113-16B containing pNW2, overexpressing VAMT encoding gene
S. cerevisiae TMB4351
TMB4150 containing pNW4, overexpressing VAMT and LK RADH encoding genes, TRP1, LEU2, HIS3
S. cerevisiae TMB4365
TMB4150 containing 2 times more copies of pNW2 than TMB4350, overexpressing VAMT encoding gene, TRP1, HIS3
S. cerevisiae TMB4367
TMB4150 containing pNW10, overexpressing VAMT encoding gene, TRP1, LEU2, HIS3
S. cerevisiae TMB4373
TMB4365 pNW4, overexpressing VAMT and LK RADH encoding genes, TRP1, HIS3
Strains VAMT (TMB4367) and VAMT + LK RADH (TMB4351) were evaluated in a batch conversion of (rac)-1-PEA to (R)-1-PEA and (R)-1-PE. In particular, the specific activity, enantioselectivity and the ability to exploit the native sugar metabolism to provide essential co-factors and co-substrates for the reaction were determined.
During the first 24 h, the reaction rate of (S)-1-PEA to ACP with VAMT + LK RADH strain (TMB4351) was with 0.014 mmol (S)-1-PEA/g dw/h nearly two-fold higher than for VAMT strain (TMB4367) with 0.008 mmol (S)-1-PEA/g dw/h (see Figure 3a and b). It decreased between 24 h and 48 h and stopped after that for both strains at a substrate conversion of about 12% (VAMT + LK RADH) and 9% (VAMT), respectively. Altogether, the kinetic resolution of (rac)-1-PEA was improved by 25% for VAMT + LK RADH strain (TMB4351) compared to VAMT strain (TMB4367).
Effect of increasing the amount of gene copy numbers of transaminase
To investigate if the limitation of the two-step reaction lied in the transamination step, a strain with elevated transaminase activity and unchanged reductase activity as compared to VAMT + LK RADH strain (TMB4351) was constructed by increasing VAMT gene copy number. Strain TMB4365 containing several copies of VAMT gene was transformed with the plasmid pNW4 containing VAMT and LK RADH generating strain TMB4373 which contained three times more copies of VAMT gene than VAMT + LK RADH strain (TMB4351). The increased gene copy number of VAMT led to a two-fold higher conversion for 3x VAMT + LK RADH strain (TMB4373) (Figure 3c) compared to VAMT + LK RADH strain (TMB4351) containing only one copy of VAMT and LK RADH genes (Figure 3b) and nearly three-fold higher conversion than for VAMT strain (TMB4367) (Figure 3a). The higher amount of transaminase increased the overall reaction rate of the kinetic resolution from 0.014 mmol (S)-1-PEA/g dw/h (TMB4351, 1x VAMT + 1x LK RADH) to 0.018 mmol (S)-1-PEA/g dw/h (TMB4373, 3x VAMT + 1x LK RADH) during the first 24 h. However, even with three copies of VAMT gene present, the reaction rate decreased during the reaction (between 48 h and 72 h, no detectable rate with VAMT + LK RADH strain (TMB4351) and 0.001 mmol (S)-1-PEA/g dw/h with 3x VAMT + LK RADH strain (TMB4373). As with VAMT + LK RADH strain (TMB4351), 3x VAMT + 1x LK RADH strain (TMB4373) showed no ACP production during the first 24 h, indicating that the reductase was efficient in reducing ACP to (R)-1-PE (Figure 3c). Between 24 h and 72 h however, nearly twice the amount of ACP (1.05 mM) was formed with 3x VAMT + LK RADH strain (TMB4373) than with VAMT + LK RADH strain (0.54 mM, TMB4351). For both strains, the highest amount of (R)-1-PE (>99% ee) was at 24 h, after which it was decreasing at about the same rate (0.002 mmol (R)-1-PE/g dw/h for VAMT + LK RADH strain, 0.001 mmol (R)-1-PE/g dw/h for 3x VAMT + LK RADH strain).
Resting vs. growing cells as biocatalyst
There was no significant difference in the product formation for resting and growing cells of VAMT strain (TMB4367, Figure 4a). On the contrary for VAMT + LK RADH strain (TMB4351), resting cells accumulated 0.54 mM ACP after 72 h (Figure 3b) but only 0.04 mM with growing cells (Figure 4b). After 72 h, the amount of (R)-1-PE was about 1 mM with both resting and growing cells, but for resting cells, nearly 1.5 mM of (R)-1-PE was produced after 24 h.
3x VAMT + LK RADH strain (TMB4373) showed five times higher production of ACP with resting (1 mM, see Figure 3c) than with growing cells (0.2 mM, see Figure 4c). The highest amount of (R)-1-PE (2.5 mM) was obtained with resting cells also after 24 h and 2.1 mM (R)-1-PE was left after 72 h; for growing cells 2.5 mM (R)-1-PE was formed after 72 h.
Glucose assimilation during the reaction
In this study, we demonstrate that recombinant yeast over-expressing heterologous transaminase and reductase genes can be used as whole-cell biocatalyst for one-pot conversion of specific amine enantiomers to alcohols with high selectivity.
The biocatalytic system only contains yeast, buffer, the racemic substrate phenylethylamine (PEA), glucose as co-substrate and pyridoxal-5’-phosphate (PLP) as co-factor, which makes it environmentally friendly, simple and cheap as compared to chemical reaction systems that often require work-up of intermediates, expensive catalysts, protective groups or several solvents. The process is also much simpler than in vitro enzymatic counterpart. For instance, simultaneous synthesis of (R)-1-PEA and (R)-1-PE with purified enzymes consisted of the following steps: Growth of E. coli cells containing ω-TA and GDH (glucose dehydrogenase), harvest, disruption, dialysis of the cell extract (addition of PLP for ω-TA) and commercially obtained ADH (alcohol dehydrogenase), addition of purified enzymes, NADPH, (rac)-1-PEA, pyruvate, glucose and buffer . Multi-step reactions are especially suitable with whole-cell systems since all enzymes necessary for operational synthetic cascade reactions can be co-expressed in the same host and thus have a minimal number of upstream steps, which results in simplified processes. For example, several steps for expression, purification, or addition of involved enzymes, co-factors, co-substrates or intermediates can be omitted which significantly reduce the cost of the process .
Baker’s yeast S. cerevisiae is used in many different industrial settings such as production of ethanol, butanol, isobutanol, succhinic acid, artemisinin and recombinant protein production . Additionally, research is carried out for the production of phenolic compounds like flavonoids and stilbenoids . It is also a well suited biocatalyst for the enantioselective conversion of (S)-1-PEA to (R)-1-PE as there is no competing endogenous transaminase activity  and very little ACP reductase activity. In addition, glucose can fuel both catalytic reactions: it is converted to the central carbon intermediate pyruvate that acts as the amine acceptor in the transamination reaction and it also regenerates, via the pentose phosphate pathway, the co-factor NADPH needed for the carbonyl reduction. Thus, there is no need for external addition of neither of these system functions, which simplifies and reduces the cost of the process .
Coupling of the transamination to a subsequent reduction of the product also led to a 25% improvement of the kinetic resolution of the racemic amine substrate, which was probably due to the lower level of ACP inhibitor. In parallel, incomplete inhibition by ACP might be due to the use of whole-cells instead of isolated enzyme, as the transaminase was not directly exposed to the bulk concentration of ACP. Previous comparison of whole-cells and cell extract of Pichia pastoris showed that the ω-transaminase was indeed inhibited stronger by ACP and at much lower concentration in cell extract than in whole-cells .
L-Alanine was found not to inhibit the transamination reaction in the whole-cell system. This is consistent with previous studies using purified ω-transaminases from Vibrio fluvialis JS17, Bacillus thuringiensis JS64 and Klebsiella pneumonia JS2F where addition of the co-product L-alanine did not inhibit the reaction to a high extent at low concentrations [22,31]. The inhibitory effect in our set-up was even lower. This may, again, be explained by the use of a whole-cell system instead of enzymes. Also, in S. cerevisiae, L-alanine can be converted by ALT1 gene product to pyruvate, converting α-ketoglutarate into L-glutamate, , or by AGX1 gene product to pyruvate, yielding L-glycine from glyoxylate . The whole-cell system is therefore beneficial for kinetic resolution where L-alanine is a by-product, as it can be removed from the reaction, shifting the thermodynamic equilibrium to the product side.
A higher amount of gene copies of the transaminase VAMT led to significant improvement in biocatalysis, indicating that the transamination reaction was the bottleneck of the cascade system. The reaction rate of the following NADPH-dependent reductase from L. kefir was, at least during the first 24 h, as fast as the reaction rate of the transaminase, as no ACP was built up. After 24 h however, ACP started accumulating, maybe because of the reduced rate of NADPH co-factor regeneration (see below).
Biocatalytic systems based on whole-cells can have major differences in the metabolic state of the cell. Resting and growing cells are both alive and metabolically active, but the addition of vitamins, trace elements and a nitrogen source increase the cost of the process. Additionally, nucleic and amino acids, lipids and other compounds are synthesized, the growing cells are less robust and cellular reactions compete for co-factors . There was no significant difference between growing and resting cells for the transamination step in our system, which indicates that the higher glycolytic flux did not lead to more available pyruvate. Alternatively, pyruvate from glucose assimilation was not limiting the reaction in any of the process set-ups. Therefore, a buffer system would be preferred as it is simpler and cheaper than a system with media as the reaction solution. However, a significant difference was observed between resting and growing cells for the reduction step, thereby confirming previous observations on diketone whole-cell reduction . With growing cells, the amount of ACP was 14 times lower for VAMT + LK RADH strain (TMB4351) and five times lower for 3x VAMT + LK RADH strain (TMB4373) than with resting cells. Low accumulation of ACP shows that the transamination and reduction rates are similar with growing cells, even after 24 h of reaction. This was more pronounced when only one copy of VAMT was present, as ACP was generated less rapidly by the cells. Additionally, after 72 h the amount of (R)-1-PE was 20% higher with growing than with resting cells with 3x VAMT + LK RADH strain (TMB4373). A higher amount of ACP can have two reasons: (1) The transamination is more efficient, and/or (2) the reduction is less efficient. Growing cells displayed higher glucose consumption rate and product formation from fermentation of glucose [34,35]; however, the intracellular concentration of pyruvate was not measured and its influence on the difference in reaction performance is therefore not known. A comparison between using glucose or adding pyruvate directly as co-substrate for whole-cell transamination with resting cells has been performed previously . The use of glucose as co-substrate had a higher initial specific reaction rate, but led to about the same final conversion as when pyruvate was added as co-substrate. This indicates that pyruvate is not limiting the reaction for resting cells. The higher glycolytic flux for growing cells could lead to faster regeneration of the co-factor NADPH  and therefore more efficient reduction of ACP. These observations lead to the conclusion that for resting cells, the amount of NADPH was too low after 24 h. When glucose consumption after 24 h decreased, less NADPH may have been regenerated and NADP+ may have accumulated, leading to a shift of the reduction towards the ketone side, which would explain the depletion of (R)-1-PE with resting cells after 24 h. The accumulation of ACP is due to further kinetic resolution of racemic 1-PEA after 24 h. For a transaminase-oxidoreductase coupled system, growing cells are therefore more suitable, unless more efficient NADPH regeneration systems can be introduced. For this strategy PGI1 gene is deleted and ZWF1 gene overexpressed, which forces the glycolytic flux through the pentose phosphate pathway and leads to efficient regeneration of NADPH for whole-cell reduction .
We could demonstrate simultaneous kinetic resolution of racemic-1-PEA to (R)-1-PEA and reduction of the ketone intermediate ACP to (R)-1-PE. Glucose was used as sole co-substrate for production of the amine acceptor pyruvate and regeneration of the co-factor NADPH. Our method shows the possibility of one-pot two-step reactions with whole-cell systems. Even if the method cannot yet compete in an industrial setting, it shows the potential of microbial cell factories for the production of useful chiral building blocks.
All chemicals were bought from VWR (Leuven, Belgium) except acetophenone (ACP), racemic 1-phenylethylamine (1-PEA), (R)-1-PEA, (S)-1-PEA and sodium pyruvate from Merck (Hohenbrunn, Germany), (R)-1-phenylethanol (PE) and (S)-1-PE from Sigma-Aldrich (Steinheim, Germany) and pyridoxal-5’-phosphate (PLP) from AppliChem (Darmstadt, Germany).
Strains, media, and cell growth
S. cerevisiae strain TMB4150 (MATa, ura3-52 MAL2-8 C SUC2) was kindly provided by Jan Knudsen, Applied Microbiology, Lund University, Sweden. E. coli strain DH5α (Life Technologies, Rockville, MD, USA) was used for subcloning. S. cerevisiae strain TMB4350  was used for the inhibition experiments. TMB4351, TMB4367 and TMB4373 (see construction below and Table 1) were used for whole-cell transamination and measurement of reductase activity. Strains were kept as 20% glycerol stocks at −80°C and grown on solid media for 1–2 days prior to experiments. Transformation and cell growth was performed as described previously  except that mineral medium  was used instead of YPG medium.
Nucleic acid manipulation
Plasmid DNA was prepared with the GeneJET Plasmid Miniprep Kit (Thermo Scientific, Rockford, IL, USA) and agarose gel DNA extraction was performed using QIAquick® Gel Extraction Kit (Qiagen GmbH, Hilden, Germany). Primers from MWG-Biotech AG (Ebersberg, Germany) and Phusion Hot Start II DNA Polymerase and dNTPs from Thermo Scientific (Rockford, IL, USA) were used for polymerase chain reactions (PCR) and performed in a GeneAmp PCR system 9700 (Applied Biosystems, Foster City, CA, USA). PCR products were purified with the GeneJET PCR Purification Kit (Thermo Scientific, Rockford, IL, USA). Sequencing was performed by MWG-Biotech AG (Ebersberg, Germany). InFusion® HD Cloning Kit (Clontech Laboratories, Mountain View, CA, USA) was used for DNA manipulation.
Primers used in this study
Sequence 5’ → 3’
LK RADH fwd
LK RADH rev
VAMT qPCR fwd
VAMT qPCR rev
TMB4373 was constructed by transformation of TMB4365 with pNW4.
Determination of relative gene copy number
Strains were grown in 5 ml YPG medium overnight, total DNA was extracted with Yeast DNA Extraction Kit (Thermo Scientific, Rockford, IL, USA) and the concentration measured with BioDrop μLite (BioDrop, Cambridge, UK). The gene copy number of the strains was determined by qPCR with a LightCycler® Nano Instrument (Roche Applied Science, IN, USA) with the following program: 95°C, 60 sec; 45x (95°C, 10 sec; 55°C, 20 sec; 72°C, 30 sec); 40°C, 60 sec. The mastermix contained 1 U Ex Taq HS polymerase (TaKaRa Bio Inc, Otsu, Shiga, Japan), 1x Ex Taq buffer, 0.2 mM dNTPs, 0.5 μM primers (see Table 2) and 1x EvaGreen (Biotium, Hayward, CA, USA). A duplicate standard curve was performed with TMB4367 (VAMT) as reference and 0.05, 0.1, 1.0, 10.0 and 20.0 ng total DNA. Duplicates of 0.1 and 10 ng total DNA of the other strains were compared to the standard curve and the resulting value was coupled to the relative amount of gene copies. The formation of the correct fragment was verified by a melting curve analysis (50°C to 97°C at 0.05°C/sec) and an agarose gel.
50 ml sealed serum flasks with magnetic stirring (140 rpm) and 5 g/l cell dry weight (dw) at 30°C were used for whole-cell transamination. For resting cells, the reaction solution contained 10 ml 100 mM sodium phosphate buffer (pH 7.0), 50–100 g/l glucose, 12–25 mM (rac)-1-PEA and 0.1 mM PLP. Vitamins, trace elements, (NH4)2SO4, MgSO4 and ergosterol were also added as in the growth media  for growing cells. For the inhibition experiment, 0–10 mM L-alanine or ACP were added from the start.
For the determination of specific enzyme activity, cells were grown until stationary phase, washed once with 25 ml water, and resuspended in sodium phosphate buffer (100 mM, pH 7.0). Cell extract was made with glass beads (0.5 mm) and precellys 24 bead beater with a cryolys cooling unit (Bertin technologies, Aix-en-Provence Cedex, France). Total protein amount was determined by Bradford with bovine serum albumin (Fermentas UAB, Vilnius, Lithuania) as standard . Reductase activity was assayed by following the oxidation of NAD (P) H at 340 nm using Ultrospec 2100pro spectrophotometer (Amersham Biosciences, Sweden). Data were collected using the software SWIFTII (Amersham Biosciences, Sweden). Samples were diluted so that the absorbance decreased linearly during 5 min. One unit of activity corresponds to 1 μmol NAD (P) H consumed per minute at 30°C. The assay contained sodium phosphate buffer (100 mM, pH 7.0), NAD (P) H (200 μM), ACP (10 mM) and cell extract.
Growth was monitored by measuring optical density at a wavelength of 620 nm (OD620) with an Ultrospec 2100pro spectrophotometer (Amersham Biosciences, Sweden). Cell dry weight determination was performed as described previously, as was determination of (R)-1-phenylethylamine, (S)-1-phenylethylamine, (R)-1-phenylethanol, (S)-1-phenylethanol, acetophenone, glucose, pyruvate, glycerol, acetate, succinate and ethanol .
We would like to thank Sven Keuris for the construction of the plasmid pNW4 and the strain TMB4351 and Johannes Hedman for discussion and support about qPCR and the determination of gene copy numbers. The Swedish Research Council FORMAS and The Royal Swedish Academy of Agriculture and Forestry are gratefully acknowledged for financial support.
- Pollard D, Woodley J: Biocatalysis for pharmaceutical intermediates: the future is now. Trends Biotechnol 2007, 25:66–73.View ArticleGoogle Scholar
- Höhne M, Bornscheuer UT: Biocatalytic routes to optically active amines. Chem Cat Chem 2009, 1:42–51.Google Scholar
- Patel RN: Biocatalytic synthesis of chiral alcohols and amino acids for development of pharmaceuticals. Biomolecules 2013, 3:741–777.View ArticleGoogle Scholar
- Said SA, Fiksdahl A: Stereoselective transformation of amines via chiral 2,4,6-triphenylpyridinium intermediates. Tetrahedron: Asymmetry 2001, 12:1947–1951.View ArticleGoogle Scholar
- Said SA, Fiksdahl A: Preparation and nucleophilic substitution of the N, N-1,2-naphthalenedisulfonylimide derivative of a chiral amine. Tetrahedron: Asymmetry 1999, 10:2627–2633.View ArticleGoogle Scholar
- Heggvik L, Fiksdahl A: N, N-Dimesylimides and N, N-dinosylimides as new leaving groups for the stereoselective nucleophilic substitution of amines. Tetrahedron: Asymmetry 1997, 8:2189–2192.View ArticleGoogle Scholar
- Rahman S, Ohno H, Tanaka T: Improved method of an unusual conversion of aliphatic amines into alcohols. Tetrahedron Lett 2001, 42:8007–8010.View ArticleGoogle Scholar
- Fuchs M, Tauber K, Sattler J, Lechner H, Pfeffer J, Kroutil W, Faber K: Amination of benzylic and cinnamic alcohols via a biocatalytic, aerobic, oxidation–transamination cascade. RSC Advances 2012, 2:6262–6265.View ArticleGoogle Scholar
- Yun H, Yang Y, Cho B, Hwang B, Kim B: Simultaneous synthesis of enantiomerically pure ( R )-1-phenylethanol and ( R )-α-methylbenzylamine from racemic α-methylbenzylamine using ω-transaminase/alcohol dehydrogenase/glucose dehydrogenase coupling reaction. Biotechnol Lett 2003, 25:809–814.View ArticleGoogle Scholar
- Bea H, Seo Y, Cha M, Kim B, Yun H: Kinetic resolution of α-methylbenzylamine by recombinant Pichia pastoris expressing ω-transaminase. Biotechnol Bioprocess Eng 2010, 15:429–434.View ArticleGoogle Scholar
- Weber N, Gorwa-Grauslund M, Carlquist M: Exploiting cell metabolism for biocatalytic whole-cell transamination by recombinant Saccharomyces cerevisiae . Appl Microbiol Biotechnol 2014, 98:4615–4624.View ArticleGoogle Scholar
- Stewart J: Organic transformations catalyzed by engineered yeast cells and related systems. Curr Opin Biotechnol 2000, 11:363–368.View ArticleGoogle Scholar
- Johanson T, Katz M, Gorwa-Grauslund M: Strain engineering for stereoselective bioreduction of dicarbonyl compounds by yeast reductases. FEMS Yeast Res 2005, 5:513–525.View ArticleGoogle Scholar
- Katz M, Frejd T, Hahn-Hägerdal B, Gorwa-Grauslund M: Efficient anaerobic whole cell stereoselective bioreduction with recombinant Saccharomyces cerevisiae . Biotech Bioeng 2003, 84:273–282.View ArticleGoogle Scholar
- Parachin NS, Carlquist M, Gorwa-Grauslund M: Comparison of engineered Saccharomyces cerevisiae and engineered Escherichia coli for the production of an optically pure keto alcohol. Appl Microbiol Biotechnol 2009, 84:487–497.View ArticleGoogle Scholar
- Bugge S, Kaspersen S, Larsen S, Nonstad U, Bjorkoy G, Sundby E, Hoff B: Structure-activity study leading to identification of a highly active thienopyrimidine based EGFR inhibitor. Eur J Med Chem 2014, 75:354–374.View ArticleGoogle Scholar
- Ma D, Pan Q, Pan S: Process for preparing (S)-N-ethyl-N-methyl-3-[1-(dimethylamino)-ethyl]-phenylcarbamate and tartrate thereof. Shanghai, China: Shanghai Zhi Xin Patent agent LTD; 2006. CN Patent 002246.Google Scholar
- Hancock J, Hoeven DV, Holland G, Jain D: Fendiline derivatives and methods of use thereof. Austin, Texas, USA: MH Voges agent; 2013. US Patent 055999.Google Scholar
- Kozai S, Maruyama T, Kimura T, Yamamoto I: Synthesis and hypnotic activities of 4-thio analogues of N 3 -substituted uridines. Chem Pharm Bull 2001, 49:1185–1188.Google Scholar
- Iwasaki A, Yamada Y, Kizaki N, Ikenaka Y, Hasegawa J: Microbial synthesis of chiral amines by ( R )-specific transamination with Arthrobacter sp. KNK168. Appl Microbiol Biotechnol 2006, 69:499–505.View ArticleGoogle Scholar
- Shin JS, Kim BG: Kinetic resolution of α-methylbenzylamine with ω-transaminase screened from soil microorganisms: application of a biphasic system to overcome product inhibition. Biotech Bioeng 1997, 55:348–358.View ArticleGoogle Scholar
- Shin JS, Kim BG: Kinetic modeling of ω-transamination for enzymatic kinetic resolution of α-methylbenzylamine. Biotech Bioeng 1998, 60:534–540.View ArticleGoogle Scholar
- Weber N, Ismail A, Gorwa-Grauslund M, Carlquist M: Biocatalytic potential of vanillin aminotransferase from Capsicum chinense . BMC Biotechnol 2014, 14:ᅟ. doi:10.1186/1472-6750-1114-1125.View ArticleGoogle Scholar
- Weckbecker A, Hummel W: Cloning, expression, and characterization of an ( R )-specific alcohol dehydrogenase from Lactobacillus kefir . Biocatal Biotransform 2006, 24:380–389.View ArticleGoogle Scholar
- Bengtsson O: Genetic traits beneficial for xylose utilization by recombinant Saccharomyces cerevisiae. In PhD thesis. Lund University: Department of Chemistry; 2008.Google Scholar
- Schrewe M, Julsing MK, Bühler B, Schmid A: Whole-cell biocatalysis for selective and productive C–O functional group introduction and modification. Chem Soc Rev 2013, 42:6346–6377.View ArticleGoogle Scholar
- Postma E, Verduyn C, Scheffers WA, Dijken JPV: Enzymic analysis of the Crabtree effect in glucose-limited chemostat cultures of Saccharomyces cerevisiae . Appl Environ Microbiol 1989, 55:468–477.Google Scholar
- Tufvesson P, Lima-Ramos J, Nordblad M, Woodley JM: Guidelines and cost analysis for catalyst production in biocatalytic processes. Org Process Res Dev 2011, 15:266–274.View ArticleGoogle Scholar
- Mattanovich D, Sauer M, Gasser B: Yeast biotechnology: teaching the old dog new tricks. Microb Cell Fact 2014, 13:34–38.View ArticleGoogle Scholar
- Tufvesson P, Fu W, Jensen JS, Woodley JM: Process considerations for the scale-up and implementation of biocatalysis. Food Bioprod Process 2010, 88:3–11.View ArticleGoogle Scholar
- Shin JS, Kim BG: Comparison of the ω-transaminases from different microorganisms and application to production of chiral amines. Biosci Biotechnol Biochem 2001, 65:1782–1788.View ArticleGoogle Scholar
- Peñalosa-Ruiz G, Aranda C, Ongay-Larios L, Colon M, Quezada H, Gonzalez A: Paralogous ALT1 and ALT2 retention and diversification have generated catalytically active and inactive aminotransferases in Saccharomyces cerevisiae . PloS One 2012, 7: doi:10.1371/journal.pone.0045702.Google Scholar
- Schlösser T, Gätgens C, Weber U, Stahmann KP: Alanine : glyoxylate aminotransferase of Saccharomyces cerevisiae -encoding gene AGX1 and metabolic significance. Yeast 2004, 21:63–73.View ArticleGoogle Scholar
- Kuhn D, Blank LM, Schmid A, Bühler B: Systems biotechnology - Rational whole-cell biocatalyst and bioprocess design. Eng Life Sci 2010, 10:384–397.View ArticleGoogle Scholar
- Benevolensky S, Clifton D, Fraenkel D: The effect of increased phosphoglucose isomerase on glucose metabolism in Saccharomyces cerevisiae . J Biol Chem 1994, 269:4878–4882.Google Scholar
- Verduyn C, Postma E, Scheffers WA, Dijken JPV: Effect of benzoic acid on metabolic fluxes in yeasts: a continuous-culture study on the regulation of respiration and alcoholic fermentation. Yeast 1992, 8:501–517.View ArticleGoogle Scholar
- Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248–254.View ArticleGoogle Scholar
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.